ISSN: 1687-8450

Journal Home

Journal of Oncology - Unclaimed

Hindawi Limited United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Journal of Oncology is a journal indexed in SJR in Oncology with an H index of 68. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1170 €. The scope of the journal is focused on oncology. It has a best quartile of -. It is published in English.

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

Categories: Oncology

Price

1170 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0

SJR Impact factor

68

H Index

129

Total Docs (Last Year)

1604

Total Docs (3 years)

5436

Total Refs

3979

Total Cites (3 years)

1599

Citable Docs (3 years)

2.32

Cites/Doc (2 years)

42.14

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Chinese Journal of Cancer Research -
Oncoscience -
European Journal of Gynaecological Oncology -
Advances in Cancer Research -

Compare this journals

Aims and Scope

Oncology

Best articles by citations

Loss of miR-200c: A Marker of Aggressiveness and Chemoresistance in Female Reproductive Cancers

Vascular Endothelial Growth Factor Plus Epidermal Growth Factor Receptor Dual Targeted Therapy in Metastatic Colorectal Cancer: Synergy or Antagonism?

A Case Report of Intraductal Papillary-Mucinous Neoplasm of the Pancreas Showing Morphologic Transformation during Followup Periods

Orthotopic Heart Transplantation and Mechanical Circulatory Support in Cancer Survivors: Challenges and Outcomes

Eosinophils and Oral Squamous Cell Carcinoma: A Short Review

Recent Advances in Image-Guided Radiotherapy for Head and Neck Carcinoma

Autophagy Regulated by Gain of Function Mutant p53 Enhances Proteasomal Inhibitor-Mediated Cell Death through Induction of ROS and ERK in Lung Cancer Cells

Modulation of CXCR4, CXCL12, and Tumor Cell Invasion Potential In Vitro by Phytochemicals

BRCA1 as a Therapeutic Target in Sporadic Epithelial Ovarian Cancer

Insights into the Role of GILT in HLA Class II Antigen Processing and Presentation by Melanoma

Genomically Driven Precision Medicine to Improve Outcomes in Anaplastic Thyroid Cancer

Prognostic Impact of Hypoxia-InduciblemiRNA-210in Patients with Lung Adenocarcinoma

SHOW MORE ARTICLES

Development of a Score Predicting Survival after Palliative Reirradiation

Precursor Lesions of High-Grade Serous Ovarian Carcinoma: Morphological and Molecular Characteristics

CYP1A1, mEH, and GSTM1 Polymophisms and Risk of Oral and Pharyngeal Cancer: A Spanish Case-Control Study

The Role of Deubiquitinases in Oncovirus and Host Interactions

Metastatic Breast Cancer or Multiple Myeloma? Camouflage by Lytic Lesions

Rare and Challenging Tumor Entity: Phyllodes Tumor of the Prostate

Integrin-Mediated Cell-Matrix Interaction in Physiological and Pathological Blood Vessel Formation

Dental Treatment in Patients with Leukemia

Chemoprevention of Head and Neck Cancer by Green Tea Extract: EGCG - The Role of EGFR Signaling and "Lipid Raft"

Breast Cancer Biology: The Multifaceted Roles of Mesenchymal Stem Cells

Selected Office Based Anticancer Treatment Strategies

Circulating Tumor Cells in Gastrointestinal Malignancies: Current Techniques and Clinical Implications